BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10648579)

  • 1. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR; Martinez OM; Krams SM; Cox K; So S; Esquivel CO
    Liver Transpl; 2000 Jan; 6(1):62-6. PubMed ID: 10648579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients.
    Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM
    Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients.
    Rogers BB; Conlin C; Timmons CF; Dawson DB; Krisher K; Andrews WS
    Pediatr Pathol Lab Med; 1997; 17(3):391-400. PubMed ID: 9185219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.
    Toyoda M; Moudgil A; Warady BA; Puliyanda DP; Jordan SC
    Pediatr Transplant; 2008 Nov; 12(7):778-84. PubMed ID: 18331541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
    Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
    Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative tissue polymerase chain reaction for Epstein-Barr virus in pediatric solid organ recipients.
    Gupta M; Filler G; Kovesi T; Shaw L; Forget C; Carpenter B; Reisman J; Feber J; Diaz-Mitoma F
    Am J Kidney Dis; 2003 Jan; 41(1):212-9. PubMed ID: 12500239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
    Lee TC; Goss JA; Rooney CM; Heslop HE; Barshes NR; Caldwell YM; Gee AP; Scott JD; Savoldo B
    Clin Transplant; 2006; 20(6):689-94. PubMed ID: 17100717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease.
    Carpentier L; Tapiero B; Alvarez F; Viau C; Alfieri C
    J Infect Dis; 2003 Dec; 188(12):1853-64. PubMed ID: 14673764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M; Böswald M; Korn K; Ruder H
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
    Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
    Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
    Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL; Strocker AM
    Laryngoscope; 2001 Jun; 111(6):997-1001. PubMed ID: 11404611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A; Nazzari C; Verzaro S; Latte MC; Fabri G; Scateni S; Raggi C; Lubrano R; Mancini C
    New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD; Hsu DT; Kichuk MR; Garvin JH; Stolar CJ; Haddad J; Stylianos S; Michler RE; Chadburn A; Knowles DM; Addonizio LJ
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.